The nigrostriatal dopamine system of aging GFRα-1 heterozygous mice: Neurochemistry, morphology and behavior

European Journal of Neuroscience

Volumn 28, Issue 8, 2008, Pages 1557-1568

  Zaman, Vandana ^a   Boger, Heather A ^a   Granholm, Ann Charlotte ^a,b   Rohrer, Baerbel ^a   Moore, Alfred ^a,b   Buhusi, Mona ^a   Gerhardt, Greg A ^c   Hoffer, Barry J ^d   Middaugh, Lawrence D ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Growth factor receptors; Monoamines; Neuropharmacology; Neurotrophic factors; Nigrostriatal system; SKF 82958

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR FAMILY RECEPTOR ALPHA 1; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; OXYGENASE; TYROSINE; UNCLASSIFIED DRUG;

AGING; ARTICLE; BEHAVIORAL SCIENCE; CELL COUNT; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; HYPERSENSITIVITY; MESOLIMBIC DOPAMINERGIC SYSTEM; MORPHOLOGICAL TRAIT; MOTOR ACTIVITY; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL;

AGING; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; HETEROZYGOTE; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; NERVE DEGENERATION; NEURAL PATHWAYS; PARKINSON DISEASE; PRESYNAPTIC TERMINALS; RECEPTORS, DOPAMINE D1; SUBSTANTIA NIGRA;

EID: 53949085352     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2008.06456.x     Document Type: Article

References (87)

1. Airavaara, M., Planken, A., Gaddnas, H., Piepponen, T.P., Saarma, M. Ahtee, L. (2004) Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice. Eur. J. Neurosci., 20, 2336 2344.
2. Akerud, P., Canals, J.M., Snyder, E.Y. Arenas, E. (2001) Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease. J. Neurosci., 21, 8108 8118.
3. Alavian, K.N., Scholz, C. Simon, H.H. (2008) Transcriptional regulation of mesencephalic dopaminergic neurons: the full circle of life and death. Mov. Disord., 23, 319 328.
4. Arvidsson, A., Kokaia, Z., Airaksinen, M.S., Saarma, M. Lindvall, O. (2001) Stroke induces widespread changes of gene expression for glial cell line-derived neurotrophic factor family receptors in the adult rat brain. Neuroscience, 106, 27 41.
5. Bergman, E., Kullberg, S., Ming, Y. Ulfhake, B. (1999) Upregulation of GFRalpha-1 and c-ret in primary sensory neurons and spinal motoneurons of aged rats. J. Neurosci. Res., 57, 153 165.
6. Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K. Seitelberger, F. (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J. Neurol. Sci., 20, 415 455.
7. Betarbet, R. Greenamyre, J.T. (2004) Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP. Exp. Neurol., 189, 393 403.
8. Betarbet, R., Turner, R., Chockkan, V., DeLong, M.R., Allers, K.A., Walters, J., Levey, A.I. Greenamyre, J.T. (1997) Dopaminergic neurons intrinsic to the primate striatum. J. Neurosci., 17, 6761 6768.
9. Bezard, E., Dovero, S., Prunier, C., Ravenscroft, P., Chalon, S., Guilloteau, D., Crossman, A.R., Bioulac, B., Brotchie, J.M. Gross, C.E. (2001) Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- lesioned macaque model of Parkinson's disease. J. Neurosci., 21, 6853 6861.
10. Bishop, C. Walker, P.D. (2003) Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats. Neuroscience, 121, 649 657.
11. Boger, H.A., Granholm, A.C., Jin, L., Nelson, M.E., Page, G.P. McGinty, J.F. (2004) Striatal gene expression profile of 12 months old GDNF heterozygous mice. Soc. Neurosci. Abstr., 725, 17.
12. Boger, H.A., Middaugh, L.D., Huang, P., Zaman, V., Smith, A.C., Hoffer, B.J., Tomac, A.C. Granholm, A.C. (2006) A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra. Exp. Neurol., 202, 336 347.
13. Borlongan, C.V., Zhou, F.C., Hayashi, T., Su, T.P., Hoffer, B.J. Wang, Y. (2001) Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats. Neurobiol. Dis., 8, 636 646.
14. Bowenkamp, K.E., Hoffman, A.F., Gerhardt, G.A., Henry, M.A., Biddle, P.T., Hoffer, B.J. Granholm, A.C. (1995) Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. Comp. Neurol., 355, 479 489.
15. Chauhan, N.B., Siegel, G.J. Lee, J.M. (2001) Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain. J. Chem. Neuroanat., 21, 277 288.
16. Chen, A.C., Eisch, A.J., Sakai, N., Takahashi, M., Nestler, E.J. Duman, R.S. (2001) Regulation of GFRalpha-1 and GFRalpha-2 mRNAs in rat brain by electroconvulsive seizure. Synapse, 39, 42 50.
17. Choi-Lundberg, D.L. Bohn, M.C. (1995) Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Brain Res. Dev. Brain Res., 85, 80 88.
18. Colebrooke, R.E., Humby, T., Lynch, P.J., McGowan, D.P., Xia, J. Emson, P.C. (2006) Age-related decline in striatal dopamine content and motor performance occurs in the absence of nigral cell loss in a genetic mouse model of Parkinson's disease. Eur. J. Neurosci., 24, 2622 2630.
19. Collier, T.J., Dung Ling, Z., Carvey, P.M., Fletcher-Turner, A., Yurek, D.M., Sladek, J.R. Jr. Kordower, J.H. (2005) Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism. Exp. Neurol., 191 (Suppl. 1 S60 S67.
20. Collier, T.J., Lipton, J., Daley, B.F., Palfi, S., Chu, Y., Sortwell, C., Bakay, R.A., Sladek, J.R. Jr. Kordower, J.H. (2007) Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism. Neurobiol. Dis., 26, 56 65.
21. Crutcher, K.A., Brothers, L. Davis, J.N. (1981) Sympathetic noradrenergic sprouting in response to central cholinergic denervation; a histochemical study of neuronal sprouting in the rat hippocampal formation. Brain Res., 210, 115 128.
22. Date, I., Aoi, M., Tomita, S., Collins, F. Ohmoto, T. (1998) GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice. Neuroreport, 9, 2365 2369.
23. Dong, A., Shen, J., Krause, M., Hackett, S.F. Campochiaro, P.A. (2007) Increased expression of glial cell line-derived neurotrophic factor protects against oxidative damage-induced retinal degeneration. J. Neurochem., 103, 1041 1052.
24. Dorce, V.A. Palermo-Neto, J. (1994) Behavioral and neurochemical changes induced by aging in dopaminergic systems of male and female rats. Physiol. Behav., 56, 1015 1019.
25. Dulawa, S.C., Grandy, D.K., Low, M.J., Paulus, M.P. Geyer, M.A. (1999) Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J. Neurosci., 19, 9550 9556.
26. Emerich, D.F., McDermott, P., Krueger, P., Banks, M., Zhao, J., Marszalkowski, J., Frydel, B., Winn, S.R. Sanberg, P.R. (1993) Locomotion of aged rats: relationship to neurochemical but not morphological changes in nigrostriatal dopaminergic neurons. Brain Res. Bull., 32, 477 486.
27. Ericson, C., Georgievska, B. Lundberg, C. (2005) Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease. Eur. J. Neurosci., 22, 2755 2764.
28. Fink, J.S. Smith, G.P. (1980) Mesolimbic and mesocortical dopaminergic neurons are necessary for normal exploratory behavior in rats. Neurosci. Lett., 17, 61 65.
29. Fox, C.M., Gash, D.M., Smoot, M.K. Cass, W.A. (2001) Neuroprotective effects of GDNF against 6-OHDA in young and aged rats. Brain Res., 896, 56 63.
30. Franklin, K.B.J., Paxinos, G. Watson, C. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego.
31. Gage, F.H., Bjorklund, A. Stenevi, U. (1983) Reinnervation of the partially deafferented hippocampus by compensatory collateral sprouting from spared cholinergic and noradrenergic afferents. Brain Res., 268, 27 37.
32. Gash, D.M., Gerhardt, G.A. Hoffer, B.J. (1998) Effects of glial cell line-derived neurotrophic factor on the nigrostriatal dopamine system in rodents and nonhuman primates. Adv. Pharmacol., 42, 911 915.
33. Gerlai, R., McNamara, A., Choi-Lundberg, D.L., Armanini, M., Ross, J., Powell-Braxton, L. Phillips, H.S. (2001) Impaired water maze learning performance without altered dopaminergic function in mice heterozygous for the GDNF mutation. Eur. J. Neurosci., 14, 1153 1163.
34. Glazner, G.W., Mu, X. Springer, J.E. (1998) Localization of glial cell line-derived neurotrophic factor receptor alpha and c-ret mRNA in rat central nervous system. J. Comp. Neurol., 391, 42 49.
35. Gnegy, M.E. Costa, E. (1980) Catecholamine receptor supersensitivity and subsensitivity in the central nervous system. Essays Neurochem. Neuropharmacol., 4, 249 282.
36. Golan, H., Stilman, M., Lev, V. Huleihel, M. (2006) Normal aging of offspring mice of mothers with induced inflammation during pregnancy. Neuroscience, 141, 1909 1918.
37. Granholm, A.C., Mott, J.L., Bowenkamp, K., Eken, S., Henry, S., Hoffer, B.J., Lapchak, P.A., Palmer, M.R., van Horne, C. Gerhardt, G.A. (1997) Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp. Brain Res., 116, 29 38.
38. Granholm, A.C., Ford, K.A., Hyde, L.A., Bimonte, H.A., Hunter, C.L., Nelson, M., Albeck, D., Sanders, L.A., Mufson, E.J. Crnic, L.S. (2002) Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome. Physiol. Behav., 77, 371 385.
39. Greenwood, C.E., Tatton, W.G., Seniuk, N.A. Biddle, F.G. (1991) Increased dopamine synthesis in aging substantia nigra neurons. Neurobiol. Aging, 12, 557 565.
40. Grondin, R., Cass, W.A., Zhang, Z., Stanford, J.A., Gash, D.M. Gerhardt, G.A. (2003) Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged rhesus monkeys. J. Neurosci., 23, 1974 1980.
41. Gundersen, H.J., Bendtsen, T.F., Korbo, L., Marcussen, N., Moller, A., Nielsen, K., Nyengaard, J.R., Pakkenberg, B., Sorensen, F.B., Vesterby, A. West, M.J. (1988) Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. Apmis., 96, 379 394.
42. Halberda, J.P., Middaugh, L.D., Gard, B.E. Jackson, B.P. (1997) DAD1- and DAD2-like agonist effects on motor activity of C57 mice: differences compared to rats. Synapse, 26, 81 92.
43. Hall, M.E., Hoffer, B.J. Gerhardt, G.A. (1989) Rapid and sensitive determination of catecholamines in small tissue samples by high pressure liquid chromatography coupled with dual-electrode coulometric electrochemical detection. LC/GC, 7, 258 265.
44. Hansen, J.T., Sakai, K., Greenamyre, J.T. Moran, S. (1995) Sprouting of dopaminergic fibers from spared mesencephalic dopamine neurons in the unilateral partial lesioned rat. Brain Res., 670, 197 204.
45. Harro, J., Oreland, L., Vasar, E. Bradwejn, J. (1995) Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation. Eur. Neuropsychopharmacol., 5, 447 455.
46. Hebert, M.A. Gerhardt, G.A. (1998) Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in fischer 344 rats. Brain Res., 797, 42 54.
47. Herrera-Marschitz, M., Forster, C. Ungerstedt, U. (1985) Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. I: Comparison between systemic and intrastriatal injections. Acta Physiol. Scand., 125, 519 527.
48. Ho, A. Blum, M. (1998) Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease. J. Neurosci., 18, 5614 5629.
49. Ingram, D.K. (2000) Age-related decline in physical activity: generalization to nonhumans. Med. Sci. Sports Exerc., 32, 1623 1629.
50. Kopp, C., Ressel, V., Wigger, E. Tobler, I. (2006) Influence of estrus cycle and ageing on activity patterns in two inbred mouse strains. Behav. Brain Res., 167, 165 174.
51. Kordower, J.H., Emborg, M.E., Bloch, J., Ma, S.Y., Chu, Y., Leventhal, L., McBride, J., Chen, E.Y., Palfi, S., Roitberg, B.Z., Brown, W.D., Holden, J.E., Pyzalski, R., Taylor, M.D., Carvey, P., Ling, Z., Trono, D., Hantraye, P., Deglon, N. Aebischer, P. (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science, 290, 767 773.
52. Kurosaki, R., Muramatsu, Y., Kato, H. Araki, T. (2004) Biochemical, behavioral and immunohistochemical alterations in MPTP-treated mouse model of Parkinson's disease. Pharmacol. Biochem. Behav., 78, 143 153.
53. Leussis, M.P. Bolivar, V.J. (2006) Habituation in rodents: a review of behavior, neurobiology, and genetics. Neurosci. Biobehav. Rev., 30, 1045 1064.
54. Mandel, R.J., Spratt, S.K., Snyder, R.O. Leff, S.E. (1997) Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc. Natl Acad. Sci. USA, 94, 14083 14088.
55. Matsuo, A., Nakamura, S. Akiguchi, I. (2000) Immunohistochemical localization of glial cell line-derived neurotrophic factor family receptor alpha-1 in the rat brain: confirmation of expression in various neuronal systems. Brain Res., 859, 57 71.
56. Misslin, R., Haberkorn, E. Ropartz, P. (1981) Responses to novelty and changes in behavior across a 3-week postoperative period in hippocampal-lesioned mice. Physiol. Behav., 27, 413 418.
57. Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Kogure, O., Kuno, S., Ichinose, H. Nagatsu, T. (2001) Glial cell line-derived neurotrophic factor in the substantia nigra from control and parkinsonian brains. Neurosci. Lett., 300, 179 181.
58. Narang, N. Wamsley, J.K. (1995) Time dependent changes in DA uptake sites, D1 and D2 receptor binding and mRNA after 6-OHDA lesions of the medial forebrain bundle in the rat brain. J. Chem. Neuroanat., 9, 41 53.
59. Nosrat, C.A., Tomac, A., Hoffer, B.J. Olson, L. (1997) Cellular and developmental patterns of expression of Ret and glial cell line-derived neurotrophic factor receptor alpha mRNAs. Exp. Brain Res., 115, 410 422.
60. Perez-Navarro, E., Arenas, E., Marco, S. Alberch, J. (1999) Intrastriatal grafting of a GDNF-producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo. Eur. J. Neurosci., 11, 241 249.
61. Pothos, E.N., Davila, V. Sulzer, D. (1998) Presynaptic recording of quanta from midbrain dopamine neurons and modulation of the quantal size. J. Neurosci., 18, 4106 4118.
62. Raisman, R., Cash, R., Ruberg, M., Javoy-Agid, F. Agid, Y. (1985) Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects. Eur. J. Pharmacol., 113, 467 468.
63. Reader, T.A. Dewar, K.M. (1999) Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum: implications for human Parkinson's disease. Neurochem. Int., 34, 1 21.
64. Reeben, M., Laurikainen, A., Hiltunen, J.O., Castren, E. Saarma, M. (1998) The messenger RNAs for both glial cell line-derived neurotrophic factor receptors, c-ret and GDNFRalpha, are induced in the rat brain in response to kainate-induced excitation. Neuroscience, 83, 151 159.
65. Rosenblad, C., Georgievska, B. Kirik, D. (2003) Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system. Eur. J. Neurosci., 17, 260 270.
66. Roth, G.S. (1986) Effects of aging on mechanisms of alpha-adrenergic and dopaminergic action. Fed. Proc., 45, 60 64.
67. Sarabi, A., Chang, C.F., Wang, Y., Hoffer, B.J. Morales, M. (2001) Time course study of GFRalpha-1 expression in an animal model of stroke. Exp. Neurol., 170, 283 289.
68. Sarabi, A., Chang, C.F., Wang, Y., Tomac, A.C., Hoffer, B.J. Morales, M. (2003) Differential expression of the cell line-derived neurotrophic factor (GDNF) receptor GFRalpha1 in heterozygous Gfralpha1 null-mutant mice after stroke. Neurosci. Lett., 341, 241 245.
69. Seeman, P., Bzowej, N.H., Guan, H.C., Bergeron, C., Reynolds, G.P., Bird, E.D., Riederer, P., Jellinger, K. Tourtellotte, W.W. (1987) Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases. Neuropsychopharmacology, 1, 5 15.
70. Serradj, N. Jamon, M. (2007) Age-related changes in the motricity of the inbred mice strains 129/sv and C57BL/6j. Behav. Brain Res., 177, 80 89.
71. Shukitt-Hale, B., Casadesus, G., Cantuti-Castelvetri, I. Joseph, J.A. (2001) Effect of age on object exploration, habituation, and response to spatial and nonspatial change. Behav. Neurosci., 115, 1059 1064.
72. Song, D.D. Haber, S.N. (2000) Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting. J. Neurosci., 20, 5102 5114.
73. Stark, A.K. Pakkenberg, B. (2004) Histological changes of the dopaminergic nigrostriatal system in aging. Cell Tissue Res., 318, 81 92.
74. Starr, B.S., Starr, M.S. Kilpatrick, I.C. (1987) Behavioural role of dopamine D1 receptors in the reserpine-treated mouse. Neuroscience, 22, 179 188.
75. Stokes, A.H., Hastings, T.G. Vrana, K.E. (1999) Cytotoxic and genotoxic potential of dopamine. J. Neurosci. Res., 55, 659 665.
76. Tomac, A., Widenfalk, J., Lin, L.F., Kohno, T., Ebendal, T., Hoffer, B.J. Olson, L. (1995) Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc. Natl Acad. Sci. USA, 92, 8274 8278.
77. Tomac, A.C., Grinberg, A., Huang, S.P., Nosrat, C., Wang, Y., Borlongan, C., Lin, S.Z., Chiang, Y.H., Olson, L., Westphal, H. Hoffer, B.J. (2000) Glial cell line-derived neurotrophic factor receptor alpha1 availability regulates glial cell line-derived neurotrophic factor signaling: evidence from mice carrying one or two mutated alleles. Neuroscience, 95, 1011 1023.
78. Trupp, M., Arenas, E., Fainzilber, M., Nilsson, A.S., Sieber, B.A., Grigoriou, M., Kilkenny, C., Salazar-Grueso, E., Pachnis, V. Arumae, U. (1996) Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature, 381, 785 789.
79. Trupp, M., Belluardo, N., Funakoshi, H. Ibanez, C.F. (1997) Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS. J. Neurosci., 17, 3554 3567.
80. Wang, J.Y., Wu, J.N., Cherng, T.L., Hoffer, B.J., Chen, H.H., Borlongan, C.V. Wang, Y. (2001) Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res., 904, 67 75.
81. West, M.J. (1993) New stereological methods for counting neurons. Neurobiol. Aging, 14, 275 285.
82. Willig, F., Palacios, A., Monmaur, P., M'Harzi, M., Laurent, J. Delacour, J. (1987) Short-term memory, exploration and locomotor activity in aged rats. Neurobiol. Aging, 8, 393 402.
83. Yurek, D.M. Fletcher-Turner, A. (2001) Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion. Brain Res., 891, 228 235.
84. Yurek, D.M., Hipkens, S.B., Hebert, M.A., Gash, D.M. Gerhardt, G.A. (1998) Age-related decline in striatal dopamine release and motoric function in brown Norway/Fischer 344 hybrid rats. Brain Res., 791, 246 256.
85. Zaman, V., Li, Z., Middaugh, L., Ramamoorthy, S., Rohrer, B., Nelson, M.E., Tomac, A.C., Hoffer, B.J., Gerhardt, G.A. Granholm, A. (2003) The noradrenergic system of aged GDNF heterozygous mice. Cell Transplant., 12, 291 303.
86. Zaman, V., Nelson, M.E., Gerhardt, G.A. Rohrer, B. (2004) Neurodegenerative alterations in the nigrostriatal system of trkB hypomorphic mice. Exp. Neurol., 190, 337 346.
87. Zambrana, C., Marco, E.M., Arranz, L., de Castro, N.M., Viveros, M.P. de la Fuente, M. (2007) Influence of aging and enriched environment on motor activity and emotional responses in mice. Ann. NY Acad. Sci., 1100, 543 552.